3CC | Third Culture Capital

Binkey is a financial technology company that helps merchants to accepts FSA and HSA as a form of payment.

Ciba Health is a digital therapeutics and virtual care platform that focuses on personalized health solutions for chronic conditions. The company employs a precision health approach to enhance both physical and mental well-being, promoting self-care and empowering patients to take charge of their health. Ciba Health's platform emphasizes patient-centered, root-cause treatment methods and a value-based care delivery model. It provides integrated care through easy access to multidisciplinary care teams, utilizing advanced technology to implement tailored treatment plans. This holistic approach addresses various aspects of health, including lifestyle, sexual, and mental health, ultimately aiming to improve overall patient outcomes.

Ciba Health is a digital therapeutics and virtual care platform that focuses on personalized health solutions for chronic conditions. The company employs a precision health approach to enhance both physical and mental well-being, promoting self-care and empowering patients to take charge of their health. Ciba Health's platform emphasizes patient-centered, root-cause treatment methods and a value-based care delivery model. It provides integrated care through easy access to multidisciplinary care teams, utilizing advanced technology to implement tailored treatment plans. This holistic approach addresses various aspects of health, including lifestyle, sexual, and mental health, ultimately aiming to improve overall patient outcomes.

Zuri Fertility is a technology company that offers a comprehensive fertility management application designed to assist couples throughout their fertility journey. The platform features a questionnaire for evaluating medical and fertility history, a home testing tracker, and a medical concierge service, all aimed at simplifying the complexities of fertility treatment. Additionally, it includes a communication support system to enhance patient engagement. By providing these resources, Zuri Fertility enables users to focus on their primary goal of starting a family while ensuring a patient-centered and efficient experience in managing their fertility process.

Voiceitt Ltd is a technology company based in Ramat Gan, Israel, founded in 2012. The company specializes in developing automatic speech recognition software aimed at enhancing communication for individuals with speech impairments and non-standard speech patterns. Voiceitt's innovative platform utilizes an AI-driven speech engine to interpret and translate distorted pronunciations into intelligible speech, thereby improving the quality of life and independence for users with motor, speech, and language disorders. Additionally, the software serves as a valuable communication tool for caregivers and family members, facilitating more effective interactions.

SimpliFed is a telehealth company founded in 2020 that offers virtual breastfeeding support to new and pregnant parents. The company focuses on providing accessible care during the peri and postnatal periods, addressing the challenges faced by parents, including sleep deprivation and concerns about infant nutrition. SimpliFed specializes in lactation and baby feeding support, as well as monitoring high-risk conditions such as hypertension and gestational diabetes. Through secure online and video-based connections, patients can engage with care navigators who guide them through their maternal care journey, helping them obtain quick answers to their questions about their infants' dietary needs.

KeyWise AI is a company that specializes in artificial intelligence software designed to objectively and precisely track brain function. Founded in 2019 by Raeanne C. Moore, the company aims to eliminate guesswork in mental health assessments. Its software generates individualized mental health metrics, facilitating precision treatments and personalized interventions for the early detection of brain disorders. By enabling users to remotely monitor and manage their mental health, KeyWise AI contributes to improved mental health outcomes and greater accessibility to mental health care.

AcousticaBio is focused on transforming intravenous medications into formulations suitable for subcutaneous injection. The company has developed a fluid processing technology that creates complex microparticles necessary for these subcutaneous formulations. This innovative approach allows for the conversion of intravenously delivered biologic products into highly concentrated, small-volume injections. By enabling patients to self-administer life-saving drugs with reduced pain and discomfort, AcousticaBio aims to streamline treatment processes, minimizing the need for lengthy hospital visits and enhancing patient convenience.

Aviwell is focused on creating healthy, natural, and sustainable solutions aimed at enhancing animal health and growth, thereby contributing to global nourishment. The company operates a microbiota-based discovery platform that leverages artificial intelligence and machine learning to bridge digital and life sciences. By developing innovative food products, Aviwell seeks to provide valuable insights into animal health, growth, and performance, ultimately supporting the agri-food industry in its efforts to sustainably meet the needs of a growing population.

SimpliFed is a telehealth company founded in 2020 that offers virtual breastfeeding support to new and pregnant parents. The company focuses on providing accessible care during the peri and postnatal periods, addressing the challenges faced by parents, including sleep deprivation and concerns about infant nutrition. SimpliFed specializes in lactation and baby feeding support, as well as monitoring high-risk conditions such as hypertension and gestational diabetes. Through secure online and video-based connections, patients can engage with care navigators who guide them through their maternal care journey, helping them obtain quick answers to their questions about their infants' dietary needs.

Intus Care, Inc. is a healthcare analytics platform focused on improving patient care and reducing hospitalizations for vulnerable and complex patients. Founded in 2018 and based in North Providence, Rhode Island, the company connects home care providers to patients through an application that tracks provider efficiency via electronic visit verification. Utilizing machine learning, the platform predicts hospital readmissions and identifies patients at high risk for hospitalizations. It also facilitates automatic patient risk grouping, enables care coordination teams to receive notifications about changes in patient health status, and supports the development of data-driven interventions and care plans. By synthesizing financial, clinical, and administrative data, Intus Care helps organizations such as nursing homes, PACE programs, and home care agencies visualize healthcare trends, ultimately aiming to deliver cost-effective healthcare solutions.

Docosan is a tech startup focused on enhancing access to quality healthcare in Vietnam through its digital marketplace. The platform enables patients to compare healthcare providers across various specialties, book appointments online at any time, and communicate with primary care assistants. By facilitating patient management, Docosan helps healthcare providers expand their client base. The service also promotes better coordination of care and generates valuable public health data. It adheres to HIPAA compliance and utilizes internationally recognized protocols, such as HL7 Fast Healthcare Interoperability Resources (FHIR), to ensure the portability of health records across different electronic health record systems. Through these efforts, Docosan is dedicated to improving healthcare for the Vietnamese population.

Pragma Bio is a biotechnology company focused on developing microbiome-based therapies for cancer and autoimmune diseases. Founded in 2018 in Millbrae, California, by Peter McCaffrey, Kovi Bessoff, Ayin Vala, and Kareem Barghouti, the company utilizes proprietary genomic sequencing, artificial intelligence, and synthetic biology techniques to identify biomarkers and therapeutics for complex immunologic disorders. Its innovative platform aggregates extensive public and private data to create a microbiome database, enabling the discovery of connections between biologically relevant data. By using this analytical approach, Pragma Bio aims to identify novel biomarkers that can help stratify patient risk and predict clinical outcomes. The company emphasizes the importance of understanding the gut-immune axis and employs machine learning to enhance the drug discovery process, offering a more efficient alternative to traditional methods and aiming to deliver improved medicines to patients more rapidly and cost-effectively.